Change of process in submission of PGD Authorisation Sheets
As you will be aware, the Community Pharmacy Development Team (CPDT) has for many years required Community Pharmacists to submit a copy of their signed Authorisation Sheet for each PGD in existence in GGC. As part of this process the Team generates an acknowledgement to the Pharmacist so that they have a record of submission.
Pharmacists are covered under the PGD as soon as they accept the professional obligations by signing the Authorisation Sheet. There is no regulatory or legal requirement for copies of the signed sheets to be submitted to the Board. The only requirement is that the Board (in the form of the CPDT) should keep a list of the Pharmacists that have signed each PGD.
A proposal put forward to redesign the process moving towards a more automated approach, was supported by both the Area Pharmaceutical Committee and CP GGC. Therefore:
With effect from 1st April 2024, Pharmacists have no need to submit their various signed PGDs to the CPDT.
The Electronic Submission Form should be completed indicating which PGDs they have signed. If an email address is provided, an automated message will be generated providing the same acknowledgement of signing. Using this method will also allow the Board to fulfil its obligations to keep a list of Pharmacists operating under the PGD and will be less onerous for the individual Pharmacist.
We understand that this change is a significant departure from a long established process and may take some time for the Community Pharmacy network to become used to. You should note that if you submit a physical PGD Authorisation Sheet to CPDT after 1st April 2024, this/these will be returned to you with a request to log your acceptance of the professional responsibility for each PGD via the new process.
Please note: This change in process will not affect payment for any services provided as part of the various PGDs.
Thank you for your co-operation.
NATIONAL PGD
Unscheduled Care v31
- PGD Unscheduled Care v31 – exp Oct 2025
- Authorisation Form v31
- What’s New v31
- PGD v31 Medicines A-Z Look-up List
- Direct Referral – Prof to Prof contact numbers v31
LOCAL SERVICE PGD
Paracetamol v6
NHS PHARMACY FIRST
- PGD Beclometasone 50μg Nasal Spray v1 – exp May 2026
- PGD Fexofenadine 120mg Tablets v1 – exp May 2026
- PGD Mometasone Furoate 50μg Nasal Spray v1 – exp May 2026
- PGD Nystatin Oral Suspension v1 – exp Oct 2026
- PGD Nystatin v1 – Supporting Information
- PGD Olopatadine 1mg/ml Eye Drops v1 – exp May 2026
- NHS PFS Hay Fever v1 Patient Assessment Form
Fusidic Acid, Nitrofurantoin, Trimethoprim v2
- PGD Fusidic Acid v 2% Cream v 2 – exp Aug 2025
- PGD Nitrofurantoin v2 – exp Aug 2025
- PGD Trimethoprim v2 – exp Aug 2025
- NHS PFS Impetigo Patient Assessment Form v2
- NHS PFS UTI Patient Assessment Form v2
Aciclovir 800 Tablets, Flucloxacillin v2
- PGD Aciclovir 800mg v2 – exp Feb 2027
- PGD Flucloxacillin v2 – exp Feb 2027
- NHS PFS Aciclovir Patient Assessment Form
- NHS PFS Flucloxacillin Patient Assessment Form
PUBLIC HEALTH
EHC v12
Progesterone Only Oral Contraception v2
- PHS Bridging Contraception Desogestrel PGD v2 – exp Sept 2027
- PHS Bridging Contraception Desogestrel PGD GP Notification Form v2
- PHS Combined EHC BC Assessment Form – Once for Scotland v1
- PHS Supporting guidance for EHC and Bridging Contraception v1
Varenicline – National PGD v1
- PGD Varenicline tablets, v1 – exp April 2027
- Assessment Form, v1
- NHS Circular – PCA(P)(2025) 06 – 10 April 2025
Amoxicillin v6, Doxycycline v6, Prednisolone v7
- PGD Amoxicillin v6 – exp Jan 2026
- PGD Doxycycline v6 – exp Jan 2026
- PGD Prednisolone v7 – exp Jan 2026
Responsible Person: Pamela Macintyre
Last Updated: 15/04/25